Search - tctmd.com

Displaying 261 - 280 of 549

Sort: Relevancy | Date

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? No, Cool Down - FFRCT Can Safely Avoid the Majority of Unnecessary Angiograms

Presenter: Justin E. Davies, Ran Kornowski, Pamela S. Douglas

October 31, 2016

Presentation TCT 2016

TCT 1490: Use of Near Infra-Red Spectroscopy With IVUS to Confirm Coronary Vasospasm as a Cause of ACS

Presenter: Jonathan M. Tobis, Giora Weisz, Nilesh Pareek

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

Presenter: Justin E. Davies, Ran Kornowski, Colin Berry

October 31, 2016

Presentation TCT 2016

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

Presenter: A. Pieter Kappetein, Marie-Claude Morice, Akiko Maehara

October 31, 2016

Presentation TCT 2016

TCT 1272: T Modified Bifurcation Technique Guided by IVUS for Left Main Bifurcation

Presenter: Emmanouil S. Brilakis, Ricardo A. Costa, Alexandre Zago

October 31, 2016

Presentation TCT 2016

Absolute Measurements of Microvascular Resistance by Thermodilution: First Human Data

Presenter: Javier Escaned, Amir Lerman, Bernard De Bruyne

October 31, 2016

Presentation TCT 2016

Absolute Measurements of Microvascular Resistance by Thermodilution: Principle and Practicalities

Presenter: Javier Escaned, Amir Lerman, Nico H.J. Pijls

October 31, 2016

Presentation TCT 2016

The Index of Microvascular Resistance

Presenter: Javier Escaned, Amir Lerman, William F. Fearon

October 31, 2016

Presentation TCT 2016

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

Presenter: Javier Escaned, Amir Lerman, Keith G. Oldroyd

October 31, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Presentation TCT 2016

FFR and CFR: Similarities, Differences, and When to Prefer Each

Presenter: Allen Jeremias, Nico H.J. Pijls, Tim P. van de Hoef

October 31, 2016

Presentation TCT 2016

TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous Coronary Intervention Within Five Minutes Using Optical Coherence Tomography

Presenter: Hector M. Garcia-Garcia, Ik-Kyung Jang, Hyuck Jun Yoon

October 31, 2016

Presentation TCT 2016

TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment of Vascular Healing Response to Sirolimus and Paclitaxel-Eluting Stents

Presenter: Hector M. Garcia-Garcia, Ik-Kyung Jang, Mariusz Tomaniak

October 31, 2016

Presentation TCT 2016

TCT 73: Serial Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing Morphologies Associated of Plaque Progression in Patients With Stable Angina Pectoris

Presenter: Hector M. Garcia-Garcia, Ik-Kyung Jang, Myong Hwa Yamamoto

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Presentation TCT 2016

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth

October 31, 2016

Presentation TCT 2016

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley

October 31, 2016

Presentation TCT 2016

Intravascular Imaging: IVUS, OCT, and NIRS

Presenter: John McB. Hodgson, Stephen P. Hoole

October 31, 2016

Advertisement

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? No, Cool Down - FFRCT Can Safely Avoid the Majority of Unnecessary Angiograms

TCT 1490: Use of Near Infra-Red Spectroscopy With IVUS to Confirm Coronary Vasospasm as a Cause of ACS

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

IVUS-guided Left Main and Non-left Main Stenting in the EXCEL Trial: Lessons From the EXCEL IVUS Core Laboratory

TCT 1272: T Modified Bifurcation Technique Guided by IVUS for Left Main Bifurcation

Absolute Measurements of Microvascular Resistance by Thermodilution: First Human Data

Absolute Measurements of Microvascular Resistance by Thermodilution: Principle and Practicalities

The Index of Microvascular Resistance

Clinical Importance and Metrics of the Microcirculation in Patients With Atherosclerosis

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Post-PCI FFR Measurements: Lessons From FAME I and II

Contrast as a Hyperemic Agent: Easier, but Sufficient?

FFR and CFR: Similarities, Differences, and When to Prefer Each

TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous Coronary Intervention Within Five Minutes Using Optical Coherence Tomography

TCT 74: A Serial Three-Year and Nine-Year Optical Coherence Tomography Assessment of Vascular Healing Response to Sirolimus and Paclitaxel-Eluting Stents

TCT 73: Serial Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing Morphologies Associated of Plaque Progression in Patients With Stable Angina Pectoris

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent

Intravascular Imaging: IVUS, OCT, and NIRS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content